Stem cell therapy (Stemedica Cell Technologies)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStem cell therapy (Stemedica Cell Technologies)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California Irvine Medical CenterSanford Burnham Prebys Medical Discovery InstituteStemedica Cell Technologies Inc +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of California Irvine Medical CenterTroitsk ClinicStemedica Cell Technologies Inc +[4] 
Active IndicationsN/A
Inactive IndicationsBrain Injuries, Traumatic

Other Information

ATC CodeN/A
Related LinksN/A